Annotation (Toggle Detail/Summary View) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Gene-Chemical Interaction Annotations
Gene-Chemical Interaction AnnotationsTerm | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (S)-amphetamine | affects response to substance | EXP | | 6480464 | TACR1 protein affects the susceptibility to Dextroamphetamine | CTD | PMID:11897087 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:731009 | 6480464 | Tetrachlorodibenzodioxin affects the expression of TACR1 mRNA | CTD | PMID:21570461 | ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of TACR1 mRNA | CTD | PMID:16483693 | arsenite(3-) | multiple interactions | ISO | RGD:731009 | 6480464 | [arsenite co-treated with Benzo(a)pyrene] results in decreased expression of TACR1 mRNA | CTD | PMID:15894712 | arsenite(3-) | decreases expression | ISO | RGD:731009 | 6480464 | arsenite results in decreased expression of TACR1 mRNA | CTD | PMID:15894712 | benzo[a]pyrene | multiple interactions | ISO | RGD:731009 | 6480464 | [arsenite co-treated with Benzo(a)pyrene] results in decreased expression of TACR1 mRNA | CTD | PMID:15894712 | benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of TACR1 mRNA | CTD | PMID:22374506 | benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of TACR1 mRNA | CTD | PMID:21839799 | benzo[a]pyrene | decreases expression | ISO | RGD:731009 | 6480464 | Benzo(a)pyrene results in decreased expression of TACR1 mRNA | CTD | PMID:15894712 | beta-amyrin | multiple interactions | ISO | RGD:731009 | 6480464 | amyrin inhibits the reaction [Cyclophosphamide results in increased expression of TACR1 protein] | CTD | PMID:18210232 | bis(2-ethylhexyl) phthalate | increases expression | EXP | | 6480464 | Diethylhexyl Phthalate results in increased expression of TACR1 mRNA | CTD | PMID:15620428 | C60 fullerene | decreases expression | EXP | | 6480464 | fullerene C60 results in decreased expression of TACR1 mRNA | CTD | PMID:19167457 | cadmium atom | increases expression | ISO | RGD:731008 | 6480464 | Cadmium results in increased expression of TACR1 mRNA | CTD | PMID:21694771 | capsaicin | increases expression | ISO | RGD:731009 | 6480464 | Capsaicin results in increased expression of TACR1 protein | CTD | PMID:21294877 | capsaicin | multiple interactions | EXP | | 6480464 | Capsaicin inhibits the reaction [[1,2-naphthoquinone co-treated with Vehicle Emissions] results in increased expression of TACR1 mRNA] | CTD | PMID:19399481 | capsaicin | increases response to substance | ISO | RGD:731009 | 6480464 | TACR1 results in increased susceptibility to Capsaicin | CTD | PMID:11166975 PMID:10360863 | capsaicin | multiple interactions | EXP | | 6480464 | Capsaicin affects the reaction [Vehicle Emissions affects the expression of TACR1 mRNA]; more ... | CTD | PMID:13680092 | capsaicin | affects expression | EXP | | 6480464 | Capsaicin affects the expression of TACR1 mRNA | CTD | PMID:13680092 | capsaicin | increases response to substance | ISO | RGD:731009 | 6480464 | TACR1 results in increased susceptibility to Capsaicin | CTD | PMID:10360863 PMID:11166975 | capsaicin | decreases expression | ISO | RGD:731009 | 6480464 | Capsaicin results in decreased expression of TACR1 mRNA; more ... | CTD | PMID:18441096 | cocaine | multiple interactions | ISO | RGD:731009 | 6480464 | HDAC5 affects the reaction [Cocaine affects the expression of TACR1 mRNA] | CTD | PMID:17988634 | cyclophosphamide | multiple interactions | ISO | RGD:731009 | 6480464 | amyrin inhibits the reaction [Cyclophosphamide results in increased expression of TACR1 protein] | CTD | PMID:18210232 | cyclophosphamide | decreases response to substance | ISO | RGD:731009 | 6480464 | TACR1 gene mutant form results in decreased susceptibility to Cyclophosphamide | CTD | PMID:10854767 | cyclophosphamide | increases expression | ISO | RGD:731009 | 6480464 | Cyclophosphamide results in increased expression of TACR1 protein | CTD | PMID:18210232 | dioxygen | increases response to substance | ISO | RGD:731009 | 6480464 | TACR1 protein results in increased susceptibility to Oxygen | CTD | PMID:11463606 | dobutamine | multiple interactions | ISO | RGD:731008 | 6480464 | Dobutamine promotes the reaction [TAC1 protein binds to and results in increased activity of TACR1 protein] | CTD | PMID:8994422 | dydrogesterone | decreases expression | ISO | RGD:731009 | 6480464 | Dydrogesterone results in decreased expression of TACR1 protein | CTD | PMID:16389545 | famotidine | multiple interactions | ISO | RGD:731009 | 6480464 | Famotidine inhibits the reaction [Acids affects the localization of TACR1 protein] | CTD | PMID:16091555 | hydrogen chloride | affects response to substance | EXP | | 6480464 | TACR1 protein affects the susceptibility to Hydrochloric Acid | CTD | PMID:11730984 | manganese atom | decreases expression | ISO | RGD:731008 | 6480464 | Manganese results in decreased expression of TACR1 mRNA | CTD | PMID:17175027 | manganese(0) | decreases expression | ISO | RGD:731008 | 6480464 | Manganese results in decreased expression of TACR1 mRNA | CTD | PMID:17175027 | manganese(II) chloride | decreases expression | ISO | RGD:731008 | 6480464 | manganese chloride results in decreased expression of TACR1 mRNA | CTD | PMID:17175027 | morphine | multiple interactions | EXP | | 6480464 | substance P-saporin inhibits the reaction [Morphine results in increased expression of TACR1 protein] | CTD | PMID:17123731 | morphine | decreases expression | EXP | | 6480464 | Morphine results in decreased expression of TACR1 protein | CTD | PMID:19428329 | morphine | increases expression | EXP | | 6480464 | Morphine results in increased expression of TACR1 protein | CTD | PMID:15964684 PMID:17123731 | morphine | increases expression | EXP | | 6480464 | Morphine results in increased expression of TACR1 protein | CTD | PMID:17123731 PMID:15964684 | morphine | multiple interactions | EXP | | 6480464 | [SR 140333 binds to and results in decreased activity of TACR1 protein] which results in increased susceptibility to Morphine | CTD | PMID:14511336 | nitroprusside | increases response to substance | EXP | | 6480464 | TACR1 protein results in increased susceptibility to Nitroprusside | CTD | PMID:16982039 | omeprazole | multiple interactions | ISO | RGD:731009 | 6480464 | Omeprazole inhibits the reaction [Acids affects the localization of TACR1 protein] | CTD | PMID:16091555 | phenylephrine | increases response to substance | EXP | | 6480464 | TACR1 protein results in increased susceptibility to Phenylephrine | CTD | PMID:16982039 | sodium cyanide | increases response to substance | EXP | | 6480464 | TACR1 protein results in increased susceptibility to Sodium Cyanide | CTD | PMID:16982039 | sucrose | multiple interactions | EXP | | 6480464 | Sucrose inhibits the reaction [TAC1 protein affects the localization of TACR1 protein] | CTD | PMID:7524481 | taurine | decreases expression | ISO | RGD:731008 | 6480464 | Taurine results in decreased expression of TACR1 mRNA | CTD | PMID:16579726 | valproic acid | decreases expression | ISO | RGD:731008 | 6480464 | Valproic Acid results in decreased expression of TACR1 mRNA | CTD | PMID:12807426 | | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Gene Ontology Annotations
Molecular Pathway Annotations| External Database Links | |
| KEGG Pathway | Calcium signaling pathway |
| Measles | |
| Neuroactive ligand-receptor interaction | |
Disease Annotations
|
|
|
Gene-Chemical Interaction Annotations
|
|
|
Gene Ontology Annotations
|
|
|
|
|
Molecular Pathway Annotations
|
| External Database Links | |
| KEGG Pathway | Calcium signaling pathway |
| Measles | |
| Neuroactive ligand-receptor interaction | |
References - curated| 1. |
Adcock IM, etal., J Mol Endocrinol. 1993 Aug;11(1):1-7. |
| 2. |
Amantini C, etal., J Pharmacol Exp Ther. 2008 Oct;327(1):215-25. Epub 2008 Jul 11. |
| 3. |
Ansar S, etal., J Neurosurg. 2007 May;106(5):881-6. |
| 4. |
Baumbauer KM, etal., Behav Neurosci. 2007 Feb;121(1):186-99. |
| 5. |
Bradesi S, etal., Gastroenterology. 2008 Dec 24. |
| 6. |
Bregeon F, etal., J Physiol. 2010 Apr 15;588(Pt 8):1309-19. Epub 2010 Feb 22. |
| 7. |
Bremer AA, etal., Eur J Pharmacol. 2001 Jul 6;423(2-3):143-7. |
| 8. |
Camara PR, etal., Eur J Pharmacol. 2008 Jul 28;589(1-3):245-50. Epub 2008 May 16. |
| 9. |
Camargo EA, etal., Pancreas. 2008 Jul;37(1):50-5. |
| 10. |
Cardenas A, etal., Scand J Gastroenterol. 2008 Mar;43(3):328-33. |
| 11. |
Chen CY, etal., J Neurosci. 2009 Mar 4;29(9):2754-61. |
| 12. |
Chen MJ and Lai YL, Toxicol Appl Pharmacol. 2003 Mar 15;187(3):178-85. |
| 13. |
Chen SS, etal., Neurosci Lett. 2008 Oct 10;443(3):257-60. Epub 2008 Jun 27. |
| 14. |
Clement P, etal., J Sex Med. 2009 Jan;6(1):126-34. |
| 15. |
Costa SK, etal., Neurosci Lett. 2002 Feb 1;318(3):158-62. |
| 16. |
Crane LH, etal., Biol Reprod. 2002 Nov;67(5):1480-7. |
| 17. |
de Lange RP, etal., Brain Res. 2008 May 30;1212:35-47. Epub 2008 Mar 20. |
| 18. |
De Swert KO, etal., Respir Res. 2009 May 15;10:37. |
| 19. |
Dib M, etal., Am J Physiol Lung Cell Mol Physiol. 2009 Oct;297(4):L687-97. Epub 2009 Jul 24. |
| 20. |
Evangelista S, etal., Neuropeptides. 2008 Oct-Dec;42(5-6):663-70. Epub 2008 Aug 19. |
| 21. |
Furuya S, etal., Cell Tissue Res. 2010 Nov;342(2):243-59. Epub 2010 Oct 22. |
| 22. |
Goto T, etal., Neuropeptides. 2007 Feb;41(1):25-31. Epub 2007 Jan 3. |
| 23. |
Guyenet PG, etal., J Neurosci 2002 May 1;22(9):3806-16. |
| 24. |
Halasz J, etal., Biol Psychiatry. 2008 Feb 1;63(3):271-8. Epub 2007 Aug 3. |
| 25. |
Hegde A, etal., J Leukoc Biol. 2007 Sep;82(3):678-85. Epub 2007 Jun 12. |
| 26. |
Hershey AD, etal., J Biol Chem 1991 Mar 5;266(7):4366-74. |
| 27. |
Hu C, etal., Am J Physiol Lung Cell Mol Physiol 2002 Aug;283(2):L494-502. |
| 28. |
Hu CP, etal., Mediators Inflamm. 2006;2006(5):84829. |
| 29. |
Ichinose M, etal., Am J Respir Crit Care Med. 1996 Mar;153(3):936-41. |
| 30. |
Ikeda H, etal., Science 2003 Feb 21;299(5610):1237-40. |
| 31. |
Joachim RA, etal., Psychosom Med. 2004 Jul-Aug;66(4):564-71. |
| 32. |
Juszczak M, etal., J Physiol Pharmacol. 2004 Dec;55(4):739-49. |
| 33. |
Juszczak M, etal., J Physiol Pharmacol. 2007 Dec;58(4):829-43. |
| 34. |
Karagiannides I, etal., Endocrinology. 2011 Jun;152(6):2197-205. Epub 2011 Apr 5. |
| 35. |
Kertes E, etal., Behav Brain Res. 2009 Mar 17;198(2):397-403. Epub 2008 Nov 24. |
| 36. |
Khan IM, etal., Neuropharmacology. 2008 Feb;54(2):269-79. Epub 2007 Oct 17. |
| 37. |
Koeda T, etal., J Physiol Sci. 2007 Dec;57(6):361-6. Epub 2007 Dec 4. |
| 38. |
Kwatra MM, etal., J Biol Chem. 1993 May 5;268(13):9161-4. |
| 39. |
Lau HY and Bhatia M, J Pathol. 2006 Feb;208(3):364-71. |
| 40. |
Li M, etal., J Inflamm (Lond). 2011 Jul 21;8(1):18. |
| 41. |
Li PC, etal., Am J Physiol Lung Cell Mol Physiol. 2008 May;294(5):L912-20. Epub 2008 Mar 7. |
| 42. |
Lin MJ, etal., Zhonghua Jie He He Hu Xi Za Zhi. 2005 Dec;28(12):820-4. |
| 43. |
Linares-Fernandez BE and Alfieri AB, J Urol. 2007 Apr;177(4):1531-6. |
| 44. |
Liu XM, etal., Neurochem Res. 2011 May 25. |
| 45. |
Malik NM, etal., Eur J Pharmacol. 2007 Jan 26;555(2-3):164-73. Epub 2006 Oct 28. |
| 46. |
Matsubara S, etal., Am J Respir Cell Mol Biol. 2008 May;38(5):501-8. Epub 2007 Dec 6. |
| 47. |
McCarson KE Neuroscience. 1999;93(1):361-70. |
| 48. |
McKay LC and Feldman JL, Am J Respir Crit Care Med. 2008 Jul 1;178(1):89-95. Epub 2008 Apr 17. |
| 49. |
Mengual E, etal., Neuroscience. 2008 Feb 6;151(3):711-24. Epub 2007 Dec 4. |
| 50. |
MGD data from the GO Consortium |
| 51. |
Min MY, etal., Neuroscience. 2008 Jun 2;153(4):1020-33. Epub 2008 Mar 19. |
| 52. |
NCBI rat LocusLink and RefSeq merged data July 26, 2002 |
| 53. |
Oslund KL, etal., Am J Respir Cell Mol Biol. 2008 Sep;39(3):279-88. Epub 2008 Apr 3. |
| 54. |
Pacharinsak C, etal., Pain. 2008 Sep 30;139(1):34-46. Epub 2008 Apr 14. |
| 55. |
Perez S, etal., J Neurochem. 2007 Dec;103(6):2153-63. Epub 2007 Oct 18. |
| 56. |
Pinto FM, etal., Endocrinology. 1999 Jun;140(6):2526-32. |
| 57. |
Pipeline to import KEGG annotations from KEGG into RGD Pathway Ontology |
| 58. |
Polidori C, etal., Peptides. 1998;19(1):149-55. |
| 59. |
Reed KL, etal., J Surg Res 2002 Nov;108(1):165-72. |
| 60. |
RGD automated data pipeline |
| 61. |
RGD automated import pipeline for gene-chemical interactions |
| 62. |
Riley J, etal., Hypertension 2002 Dec;40(6):823-6. |
| 63. |
Seybold VS, etal., J Neurosci 2003 Mar 1;23(5):1816-24. |
| 64. |
Shi X, etal., Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2003 Jul;15(7):422-5. |
| 65. |
Sio SW, etal., Am J Respir Crit Care Med. 2010 Jan 1;181(1):36-46. Epub 2009 Oct 1. |
| 66. |
Sio SW, etal., J Immunol. 2008 Jun 15;180(12):8333-41. |
| 67. |
Tentative Sequence Data IDs. TIGR Gene Index, Rat Data |
| 68. |
Thomson LM, etal., J Pain. 2008 Jan;9(1):11-9. Epub 2007 Oct 24. |
| 69. |
Turner DJ, etal., Ann Surg. 2007 Mar;245(3):408-14. |
| 70. |
Wang Y, etal., Am J Physiol Regul Integr Comp Physiol. 2008 May;294(5):R1517-23. Epub 2008 Mar 12. |
| 71. |
Xie C, etal., J Pharmacol Exp Ther. 2008 Jun;325(3):751-7. Epub 2008 Mar 25. |
| 72. |
Xue J, etal., Zhonghua Er Bi Yan Hou Ke Za Zhi. 2000 Aug;35(4):247-50. |
| 73. |
Zhang H, etal., J Neurosci. 2007 Oct 31;27(44):12067-77. |
| 74. |
Zhang X, etal., Am J Physiol Regul Integr Comp Physiol. 2008 Dec;295(6):R2084-96. Epub 2008 Oct 22. |
References - uncurated| PubMed | 11815365 |
| 11876485 | |
| 11950831 | |
| 11959652 | |
| 12031786 | |
| 12106686 | |
| 12169105 | |
| 12384463 | |
| 12402039 | |
| 12421623 | |
| 12508374 | |
| 12648611 | |
| 12687689 | |
| 12892378 | |
| 12893626 | |
| 12958028 | |
| 14632686 | |
| 14766794 | |
| 14988833 | |
| 15019566 | |
| 15033437 | |
| 15121234 | |
| 15128739 | |
| 15390113 | |
| 15633223 | |
| 15703395 | |
| 15751026 | |
| 15782105 | |
| 15800377 | |
| 15896914 | |
| 16136007 | |
| 16239038 | |
| 16297989 | |
| 16461432 | |
| 16467532 | |
| 16477146 | |
| 16763782 | |
| 16782701 | |
| 16849335 | |
| 16982039 | |
| 17023055 | |
| 17309799 | |
| 17366610 | |
| 17468202 | |
| 17495222 | |
| 17540463 | |
| 17627972 | |
| 17640051 | |
| 17974009 | |
| 17977663 | |
| 17981325 | |
| 18479828 | |
| 18615498 | |
| 18634782 | |
| 18655130 | |
| 18656313 | |
| 18673452 | |
| 19015883 | |
| 19200070 | |
| 19222484 | |
| 19224600 | |
| 19258024 | |
| 19296480 | |
| 19344710 | |
| 19429049 | |
| 19464118 | |
| 19490080 | |
| 19563686 | |
| 19575822 | |
| 19699779 | |
| 20059697 | |
| 20125052 | |
| 20128799 | |
| 20218316 | |
| 20933035 | |
| 21166923 | |
| 21451051 | |
| 2154852 | |
| 21565534 | |
| 21837425 | |
| 21958872 | |
| 22243518 | |
| 22540287 | |
| 22734902 | |
| 22765158 | |
| 22820943 | |
| 22849826 | |
| 22963197 | |
| 2478537 |
RGD Disease Portals| Tacr1 has been annotated in the following RGD Disease Portals. |
|||||||
![]() |
| ||||||
![]() |
| ||||||
![]() |
| ||||||
![]() |
| ||||||
![]() |
| ||||||
![]() |
| ||||||
![]() |
| ||||||
Candidate Gene Status
Comparative Map Data| Tacr1 (Rattus norvegicus) |
|
|||||||||||||||||||||||||||||||||||
| TACR1 (Homo sapiens) |
|
|||||||||||||||||||||||||||||||||||
| Tacr1 (Mus musculus) |
|
Position Markers| D4Mgh17 |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||
| D4Wox19 |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||
| D4Mit23 |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||
| D4Arb39 |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||
| D0Got964 |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RH138512 |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||
| UniSTS:480302 |
|
QTLs in Region (RGSC Genome Assembly v3.4)| The following QTLs overlap with this region. | ![]() | Full Report | ![]() | CSV | ![]() | TAB | ![]() | Printer | ![]() | Gviewer |
Nucleotide Sequences| Nucleotide RefSeqs | NM_012667 | (Get FASTA) | Search GEO for Microarray Profiles |
| XM_003749783 | (Get FASTA) | Search GEO for Microarray Profiles | |
| XM_003753911 | (Get FASTA) | Search GEO for Microarray Profiles | |
| GenBank Nucleotide | AABR06031992 | (Get FASTA) | Search GEO for Microarray Profiles |
| AABR06032000 | (Get FASTA) | Search GEO for Microarray Profiles | |
| AABR06032001 | (Get FASTA) | Search GEO for Microarray Profiles | |
| AABR06032002 | (Get FASTA) | Search GEO for Microarray Profiles | |
| AABR06032003 | (Get FASTA) | Search GEO for Microarray Profiles | |
| AAHX01031220 | (Get FASTA) | Search GEO for Microarray Profiles | |
| AAHX01031221 | (Get FASTA) | Search GEO for Microarray Profiles | |
| AAHX01031222 | (Get FASTA) | Search GEO for Microarray Profiles | |
| AAHX01031223 | (Get FASTA) | Search GEO for Microarray Profiles | |
| AAHX01031224 | (Get FASTA) | Search GEO for Microarray Profiles | |
| CH473957 | (Get FASTA) | Search GEO for Microarray Profiles | |
| J05097 | (Get FASTA) | Search GEO for Microarray Profiles | |
| M31477 | (Get FASTA) | Search GEO for Microarray Profiles | |
| M64232 | (Get FASTA) | Search GEO for Microarray Profiles | |
| M64233 | (Get FASTA) | Search GEO for Microarray Profiles | |
| M64234 | (Get FASTA) | Search GEO for Microarray Profiles | |
| M64235 | (Get FASTA) | Search GEO for Microarray Profiles | |
| M64236 | (Get FASTA) | Search GEO for Microarray Profiles |
| RefSeq Acc Id: | NM_012667 | ||||||||||||||||||||
| RefSeq Status: | PROVISIONAL | ||||||||||||||||||||
| Type: | CODING | ||||||||||||||||||||
| Protein Acc Id: | NP_036799 | ||||||||||||||||||||
| Position: |
|
| RefSeq Acc Id: | XM_003749783 | ||||||||||
| RefSeq Status: | |||||||||||
| Type: | CODING | ||||||||||
| Protein Acc Id: | XP_003749831 | ||||||||||
| Position: |
|
| RefSeq Acc Id: | XM_003753911 |
| RefSeq Status: | |
| Type: | CODING |
| Protein Acc Id: | XP_003753959 |
| Position: | No map positions available. |
Protein Sequences| Protein RefSeqs | NP_036799 | (Get FASTA) |
| XP_003749831 | (Get FASTA) | |
| XP_003753959 | (Get FASTA) | |
| GenBank Protein | AAA42175 | (Get FASTA) |
| AAA42176 | (Get FASTA) | |
| AAB59726 | (Get FASTA) | |
| EDL91094 | (Get FASTA) | |
| EDL91095 | (Get FASTA) | |
| P14600 | (Get FASTA) |
Strain Sequence Variants
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
External Database Links| Database | Acc Id | Source(s) |
| Ensembl Genes | ENSRNOG00000005853 | UniProtKB/Swiss-Prot |
| Ensembl Protein | ENSRNOP00000007984 | UniProtKB/Swiss-Prot |
| Ensembl Transcript | ENSRNOT00000007984 | UniProtKB/Swiss-Prot |
| Entrez Gene | 24807 | ENTREZGENE |
| Germonline | ENSRNOG00000005853 | UniProtKB/Swiss-Prot |
| HomoloGene Group ID | 20288 | ENTREZGENE |
| InterPro | 7TM_GPCR_Rhodpsn | UniProtKB/Swiss-Prot |
| GPCR_Rhodpsn_supfam | UniProtKB/Swiss-Prot | |
| Neurokn_rcpt | UniProtKB/Swiss-Prot | |
| NK1_rcpt | UniProtKB/Swiss-Prot | |
| IPI | IPI00207210 | UniProtKB/Swiss-Prot |
| KEGG Report | rno:24807 | ENTREZGENE, UniProtKB/Swiss-Prot |
| Pfam | 7tm_1 | UniProtKB/Swiss-Prot |
| PRINTS | GPCRRHODOPSN | UniProtKB/Swiss-Prot |
| NEUROKININ1R | UniProtKB/Swiss-Prot | |
| NEUROKININR | UniProtKB/Swiss-Prot | |
| PROSITE | G_PROTEIN_RECEP_F1_1 | UniProtKB/Swiss-Prot |
| G_PROTEIN_RECEP_F1_2 | UniProtKB/Swiss-Prot | |
| TIGR | TC233578 | |
| UniGene | Rn.89609 | ENTREZGENE |
| UniProt | NK1R_RAT | UniProtKB/Swiss-Prot |
Nomenclature History| Date | Current Symbol | Current Name | Previous Symbol | Previous Name | Description | Reference | Status |
|---|---|---|---|---|---|---|---|
| 2001-06-20 | Tacr1 | Tachykinin 1 receptor | Name updated | 461 | APPROVED | ||
| 2001-06-20 | Tac1r | Tachykinin 1 receptor (substance P receptor, neurokinin 1 receptor) | Symbol withdrawn, duplicate of Tacr1 (RGD:3811) | 461 | WITHDRAWN |
RGD Curation Notes| Note Type | Note | Reference |
|---|---|---|
| gene_expression | mRNA is stable and expressed in low levels in the lungs | 625601 |
| gene_expression | expression declined with age in the lungs of pathogen free rats | 625601 |
| gene_process | mediates the respiratory stimulant effect of substance P | 625695 |
| More on Tacr1 | |
![]() |
Entrez Gene |
![]() |
Ensembl Gene |
![]() | Genome Browser |
![]() |
NCBI Map Viewer |
![]() |
Vista |
![]() |
Vista + UCSC |
| RGD Object Information | |
| RGD ID: | 3811 |
| Created: | 2000-05-25 |
| Species: | Rattus norvegicus |
| Last Modified: | 2013-05-14 |
| Status: | ACTIVE |
© Bioinformatics Program, HMGC at the Medical College of Wisconsin
RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.




